A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice (Q38980572)

8 September 2017

title

A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice (English)

1 reference

8 September 2017

8

1 reference

8 September 2017

Borna Payandemehr

1

1 reference

8 September 2017

Mahsima Khoshneviszadeh

2

1 reference

8 September 2017

Bardia Varastehmoradi

3

1 reference

8 September 2017

Ramtin Gholizadeh

4

1 reference

8 September 2017

Taraneh Bahremand

5

1 reference

8 September 2017

Hossein Attar

6

1 reference

8 September 2017

Arash Bahremand

7

1 reference

8 September 2017

publication date

28 July 2015

1 reference

8 September 2017

published in

Neurochemical Research

1 reference

8 September 2017

volume

40

1 reference

8 September 2017

issue

9

1 reference

8 September 2017

page(s)

1819-1828

1 reference

Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Effect of licofelone--a dual COX/5-LOX inhibitor in intracerebroventricular streptozotocin-induced behavioral and biochemical abnormalities in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Anti-inflammatory effect of licofelone against various inflammatory challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Cyclooxygenase in epilepsy: from perception to application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Nitric oxide-donor compounds inhibit lipoxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-mediated inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

The pivotal role of nitric oxide: effects on the nervous and immune systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Brain iNOS: current understanding and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Role of nitric oxide in additive anticonvulsant effects of agmatine and morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Regulation of cyclooxygenase enzymes by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Involvement of nitric oxide-cGMP pathway in the anticonvulsant effects of lithium chloride on PTZ-induced seizure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Cyclooxygenase-2 in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Sustained induction of prostaglandin endoperoxide synthase-2 by seizures in hippocampus. Inhibition by a platelet-activating factor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions: Possible mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Putative role of neuronal 5-lipoxygenase in an aging brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

5-Lipoxygenase and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

CJ-13610, an orally active inhibitor of 5-lipoxygenase is efficacious in preclinical models of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Changes in free fatty acids of brain by drug-induced convulsions, electroshock and anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Involvement of the arachidonic acid cascade in the hypersusceptibility to pentylenetetrazole-induced seizure during diazepam withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Evaluation of Cissus quadrangularis extracts as an inhibitor of COX, 5-LOX, and proinflammatory mediators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

RETRACTED: Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Effect of naproxen, a non-selective cyclo-oxygenase inhibitor, on pentylenetetrazol-induced kindling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Ibuprofen: effect on inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Pharmacological inhibition of inducible nitric oxide synthase attenuates the development of seizures in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS-/-) before and after pentylenetetrazole kindling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-015-1669-Z

Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats

21 January 2018

1 reference

12 December 2020

Anticonvulsant action of celecoxib (alone and in combination with sub-threshold dose of phenytoin) in electroshock induced convulsion

1 reference

12 December 2020

Nitric oxide mediates the anticonvulsant effects of thalidomide on pentylenetetrazole-induced clonic seizures in mice

1 reference

12 December 2020

Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro

1 reference

12 December 2020

Erythropoietin pretreatment suppresses seizures and prevents the increase in inflammatory mediators during pentylenetetrazole-induced generalized seizures

1 reference

12 December 2020

Anticonvulsant effect of celecoxib on pentylenetetrazole-induced convulsion: Modulation by NO pathway

1 reference

12 December 2020

Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2

1 reference

12 December 2020

Chronic administration of atorvastatin induced anti-convulsant effects in mice: The role of nitric oxide

1 reference

12 December 2020

Molecular mechanisms and therapeutic strategies related to nitric oxide.

1 reference

12 December 2020

Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis

1 reference

12 December 2020

10.1007/S11064-015-1669-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1045044642

0 references

1 reference